Rocket Pharmaceuticals Inc (RCKT)

$3.49 -0.11 (-3.06%)
Market Cap 392.84M
Revenue (ttm) 0.00
Net Income (ttm) -223.12M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 2,334,000
Avg Vol 3,591,012
Day's Range N/A - N/A
Shares Out 109.12M
Stochastic %K 24%
Beta 0.57
Analysts Sell
Price Target $8.48

Company Profile

Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a late-stage biotechnology company that focuses on developing, manufacturing, and selling of genetic therapies for rare and devastating diseases in the United States. It develops in vivo adeno-associated viral (AAV) programs, which include programs for Danon disease (DD), a multi-organ lysosomal-associated disorder leading to early death due to heart failure (RP-A501), which is in Phase 2 trial; Plakophilin-2 Arrhythmogeni...

Industry: Biotechnology
Sector: Healthcare
Phone: 609 659 8001
Address:
9 Cedarbrook Drive, Cranbury, United States
3day
3day Apr. 10 at 11:13 PM
$RCKT well next week is make or break on them 5$ calls boys
1 · Reply
168_swingit
168_swingit Apr. 10 at 9:20 PM
$RCKT following the lead of Artemis II. Looks like it's doing its own splash down! 🤣
0 · Reply
yumkatel
yumkatel Apr. 10 at 8:53 PM
$RCKT rotten ceo with rotten poosy
0 · Reply
jinzhou5042
jinzhou5042 Apr. 10 at 5:48 PM
$RCKT This is an extremely boring one.
0 · Reply
geegor
geegor Apr. 10 at 9:47 AM
$RCKT Just single share games at dawn, can go back to sleep now 🥱
0 · Reply
Omarking79
Omarking79 Apr. 10 at 9:27 AM
$RCKT uhmmmmm....movement
0 · Reply
Supereddy
Supereddy Apr. 10 at 8:31 AM
$RCKT hmmm? Wht happened?
1 · Reply
nys5
nys5 Apr. 10 at 8:31 AM
$RCKT someone just bought a huge amount
0 · Reply
yumkatel
yumkatel Apr. 9 at 10:38 PM
$RCKT By now, even FDA-disapproved stock should have recovered. This frustrating trash was handled by someone who isn't doing a very good job. fooking looser ceo
1 · Reply
Newbilly
Newbilly Apr. 9 at 8:28 PM
$RCKT Move that PRV for 225m and post that shit by EOM
1 · Reply
Latest News on RCKT
Rocket Pharma shares climb as FDA approves first therapy for deadly childhood disorder

Mar 27, 2026, 7:27 AM EDT - 14 days ago

Rocket Pharma shares climb as FDA approves first therapy for deadly childhood disorder

Rocket Pharmaceuticals Announces FDA Approval of KRESLADI™ for Pediatric Patients with Severe Leukocyte Adhesion Deficiency-I (LAD-I)

Mar 27, 2026, 7:00 AM EDT - 14 days ago

Rocket Pharmaceuticals Announces FDA Approval of KRESLADI™ for Pediatric Patients with Severe Leukocyte Adhesion Deficiency-I (LAD-I)

Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Progress

Feb 26, 2026, 4:00 PM EST - 6 weeks ago

Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Progress

Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences

Feb 23, 2026, 7:00 AM EST - 6 weeks ago

Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences

Rocket Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Jan 5, 2026, 7:00 AM EST - 3 months ago

Rocket Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Rocket Pharmaceuticals to Participate in the 8th Annual Evercore Healthcare Conference

Nov 25, 2025, 7:00 AM EST - 4 months ago

Rocket Pharmaceuticals to Participate in the 8th Annual Evercore Healthcare Conference

Rocket Pharmaceuticals Reports Third Quarter 2025 Financial Results and Highlights Recent Progress

Nov 6, 2025, 4:00 PM EST - 5 months ago

Rocket Pharmaceuticals Reports Third Quarter 2025 Financial Results and Highlights Recent Progress

FDA Acceptance Of Rocket Pharmaceuticals' Lead Gene Therapy Application Reestablishes Momentum For Stock

Oct 14, 2025, 2:27 PM EDT - 6 months ago

FDA Acceptance Of Rocket Pharmaceuticals' Lead Gene Therapy Application Reestablishes Momentum For Stock

Rocket Pharmaceuticals Announces FDA Acceptance of BLA Resubmission of KRESLADI™ for the Treatment of Severe Leukocyte Adhesion Deficiency-I (LAD-I)

Oct 14, 2025, 7:00 AM EDT - 6 months ago

Rocket Pharmaceuticals Announces FDA Acceptance of BLA Resubmission of KRESLADI™ for the Treatment of Severe Leukocyte Adhesion Deficiency-I (LAD-I)

Rocket Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Oct 10, 2025, 4:00 PM EDT - 6 months ago

Rocket Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Rocket Pharmaceuticals withdraws US application of gene therapy for rare blood disorder

Oct 3, 2025, 7:11 AM EDT - 6 months ago

Rocket Pharmaceuticals withdraws US application of gene therapy for rare blood disorder

Gene Therapy Trial Can Restart After Patient Death, FDA Says. The Sector Remains Depressed.

Aug 20, 2025, 11:02 AM EDT - 8 months ago

Gene Therapy Trial Can Restart After Patient Death, FDA Says. The Sector Remains Depressed.

FDA Lifts Rocket Pharmaceuticals Study Hold For Rare Disease Gene Therapy

Aug 20, 2025, 9:31 AM EDT - 8 months ago

FDA Lifts Rocket Pharmaceuticals Study Hold For Rare Disease Gene Therapy

US FDA lifts clinical hold on Rocket Pharmaceuticals' gene therapy trial

Aug 20, 2025, 7:09 AM EDT - 8 months ago

US FDA lifts clinical hold on Rocket Pharmaceuticals' gene therapy trial

Rocket Pharmaceuticals Announces FDA Has Lifted the Clinical Hold on the Pivotal Phase 2 Trial of RP-A501 for the Treatment of Danon Disease

Aug 20, 2025, 7:00 AM EDT - 8 months ago

Rocket Pharmaceuticals Announces FDA Has Lifted the Clinical Hold on the Pivotal Phase 2 Trial of RP-A501 for the Treatment of Danon Disease

DEADLINE NEXT WEEK: Berger Montague Advises Rocket Pharmaceuticals (NASDAQ: RCKT) Investors to Contact the Firm Before August 11, 2025

Aug 8, 2025, 2:16 PM EDT - 8 months ago

DEADLINE NEXT WEEK: Berger Montague Advises Rocket Pharmaceuticals (NASDAQ: RCKT) Investors to Contact the Firm Before August 11, 2025

Rocket Pharmaceuticals Reports Second Quarter 2025 Financial Results and Highlights Recent Progress

Aug 7, 2025, 4:00 PM EDT - 8 months ago

Rocket Pharmaceuticals Reports Second Quarter 2025 Financial Results and Highlights Recent Progress

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rocket Pharmaceuticals

Jul 30, 2025, 6:29 PM EDT - 9 months ago

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rocket Pharmaceuticals

What's Going On With Sarepta, Capricor And Other Gene Therapy Stocks On Wednesday?

Jul 30, 2025, 11:07 AM EDT - 9 months ago

What's Going On With Sarepta, Capricor And Other Gene Therapy Stocks On Wednesday?

CAPR SRPT CABA NGNE NTLA QURE

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rocket Pharmaceuticals

Jul 29, 2025, 10:26 AM EDT - 9 months ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rocket Pharmaceuticals

Rocket Refocuses Pipeline As Gene Therapy Sentiment Sours

Jul 25, 2025, 3:02 PM EDT - 9 months ago

Rocket Refocuses Pipeline As Gene Therapy Sentiment Sours

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of August 11, 2025 in Rocket Pharmaceuticals, Inc. Lawsuit – RCKT

Jul 24, 2025, 4:02 PM EDT - 9 months ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of August 11, 2025 in Rocket Pharmaceuticals, Inc. Lawsuit – RCKT

Rocket Pharmaceuticals Announces Strategic Corporate Reorganization and Pipeline Prioritization of Cardiovascular Programs

Jul 24, 2025, 7:00 AM EDT - 9 months ago

Rocket Pharmaceuticals Announces Strategic Corporate Reorganization and Pipeline Prioritization of Cardiovascular Programs

Rocket Pharmaceuticals Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for RP-A601 Gene Therapy for PKP2-Arrhythmogenic Cardiomyopathy

Jul 17, 2025, 7:00 AM EDT - 9 months ago

Rocket Pharmaceuticals Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for RP-A601 Gene Therapy for PKP2-Arrhythmogenic Cardiomyopathy

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rocket Pharmaceuticals

Jul 11, 2025, 10:25 AM EDT - 9 months ago

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rocket Pharmaceuticals

Berger Montague PC Investigates Rocket Pharmaceuticals (RCKT) Over Safety Disclosures and Stock Drop

Jul 9, 2025, 5:16 PM EDT - 9 months ago

Berger Montague PC Investigates Rocket Pharmaceuticals (RCKT) Over Safety Disclosures and Stock Drop

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of August 11, 2025 in Rocket Lawsuit - RCKT

Jul 7, 2025, 9:00 AM EDT - 9 months ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of August 11, 2025 in Rocket Lawsuit - RCKT

Rocket Pharmaceuticals Announces FDA IND Clearance of RP-A701 for the Treatment of BAG3-associated Dilated Cardiomyopathy

Jun 30, 2025, 7:00 AM EDT - 10 months ago

Rocket Pharmaceuticals Announces FDA IND Clearance of RP-A701 for the Treatment of BAG3-associated Dilated Cardiomyopathy

3day
3day Apr. 10 at 11:13 PM
$RCKT well next week is make or break on them 5$ calls boys
1 · Reply
168_swingit
168_swingit Apr. 10 at 9:20 PM
$RCKT following the lead of Artemis II. Looks like it's doing its own splash down! 🤣
0 · Reply
yumkatel
yumkatel Apr. 10 at 8:53 PM
$RCKT rotten ceo with rotten poosy
0 · Reply
jinzhou5042
jinzhou5042 Apr. 10 at 5:48 PM
$RCKT This is an extremely boring one.
0 · Reply
geegor
geegor Apr. 10 at 9:47 AM
$RCKT Just single share games at dawn, can go back to sleep now 🥱
0 · Reply
Omarking79
Omarking79 Apr. 10 at 9:27 AM
$RCKT uhmmmmm....movement
0 · Reply
Supereddy
Supereddy Apr. 10 at 8:31 AM
$RCKT hmmm? Wht happened?
1 · Reply
nys5
nys5 Apr. 10 at 8:31 AM
$RCKT someone just bought a huge amount
0 · Reply
yumkatel
yumkatel Apr. 9 at 10:38 PM
$RCKT By now, even FDA-disapproved stock should have recovered. This frustrating trash was handled by someone who isn't doing a very good job. fooking looser ceo
1 · Reply
Newbilly
Newbilly Apr. 9 at 8:28 PM
$RCKT Move that PRV for 225m and post that shit by EOM
1 · Reply
yumkatel
yumkatel Apr. 9 at 3:58 PM
$RCKT this fooking hoe is allergic to green?
1 · Reply
Nathanbrian
Nathanbrian Apr. 9 at 2:42 PM
$RCKT this can’t be any more boring
0 · Reply
Tradefun1979
Tradefun1979 Apr. 9 at 11:36 AM
$RCKT
0 · Reply
Tradefun1979
Tradefun1979 Apr. 9 at 11:21 AM
$RCKT
0 · Reply
Chickenforyou
Chickenforyou Apr. 8 at 9:50 PM
$RCKT wondering when they will sell PRV
1 · Reply
Tradefun1979
Tradefun1979 Apr. 8 at 5:42 PM
$RCKT
0 · Reply
LoveRetailFroth
LoveRetailFroth Apr. 8 at 3:52 PM
$AMLX Good Morning ☕️ 52 Wk high 17.42 🚀 $40! $RXRX $SANA $TEMT $RCKT
1 · Reply
SD4828
SD4828 Apr. 8 at 2:34 PM
$RCKT does any know if the ATM offering is still open or done?
1 · Reply
Stonski
Stonski Apr. 8 at 12:49 PM
$PSTV at least it didn’t pull a $RCKT with fda news 😭😭 GLTA .. playing fda news feels bearish nowadays
1 · Reply
Tradefun1979
Tradefun1979 Apr. 8 at 12:14 PM
$RCKT
0 · Reply
Tradefun1979
Tradefun1979 Apr. 8 at 8:23 AM
$RCKT
0 · Reply
ryyyyyy
ryyyyyy Apr. 8 at 2:44 AM
$RCKT if the trial for danon disease shows a positive result, i think the company will really have a potential for something big or a buyout
1 · Reply